Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified Using Nickel-NTA Agarose (original) (raw)

References

  1. Oaks, S.C., Mitchell, V.S., Pearson, G.W. and Carpenter, C.C.I. (Eds.) 1991. Malaria: Obstacles and opportunities: A report of the Committee for the Study on Malaria Prevention and Control. National Academy Press, Washington, D.C.
  2. Kaslow, D.C. 1993. Transmission-blocking immunity against malaria and other vector-borne diseases. Curr. Opinion in Immunol. 5: 557–565.
    Article CAS Google Scholar
  3. Kaslow, D.C., Quakyi, I.A., Syin, C., Raum, M.G., Keister, D.B., Coligan, J.E., McCutchan, T.F. and Miller, L.H. 1988. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 333: 74–76.
    Article CAS Google Scholar
  4. Kaslow, D.C., Isaacs, S., Quakyi, I.A., Gwadz, R.W., Moss, B. and Keister, D.B. 1991. Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science 252: 1310–1313.
    Article CAS Google Scholar
  5. Barr, P.J., Green, K.M., Gibson, H.L., Bathurst, I.C., Quakyi, I.A. and Kaslow, D.C. 1991. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med. 174: 1203–1208.
    Article CAS Google Scholar
  6. Kaslow, D.C., Bathurst, I.C., Keister, D.B., Campbell, G.H., Adams, S., Morris, C.L., Sullivan, J.S., Barr, P.J. and Collins, W.E. 1993. Safety, immunogenicity and in vitro efficacy of a muramyl tripeptide-based malaria transmission-blocking vaccine in an Aotus nancymai monkey model. Vaccine Res. 2: 95–103.
    Google Scholar
  7. Price, V., Mochizuki, D., March, C.J., Cosman, D., Deeley, M.C., Klinke, R., Clevenger, W., Gillis, S., Baker, P. and Urdal, D. 1987. Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene 55: 287–293.
    Article CAS Google Scholar
  8. Crowe, J. and Henco, K. 1992. The QIA expressionist. QIAGEN, Inc. Chats-worth, California.
    Google Scholar
  9. Tøttrup, H.V. and Carlsen, S. 1990. A process for the production of human proinsulin in Saccharomyces cerevisiae. Biotech. Bioeng. 35: 339–348.
    Article Google Scholar
  10. Porro, D., Martegani, E., Tura, E. and Ranzi, B.M. 1991. Development of a pH-controlled fed-batch system for budding yeast. Res. Microbiol. 142: 535–539.
    Article CAS Google Scholar
  11. Hochuli, E., Barnsworth, W., Döbeli, H., Gentz, R. and Sfuber, D. 1988. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology 6: 1321–1325.
    CAS Google Scholar
  12. O'Shannessy, D.J., Voorstad, P.J. and Quarles, R.H. 1987. Quantitation of glycoproteins on electroblots using the biotin-streptavidin complex. Anal. Biochem. 163: 204–209.
    Article CAS Google Scholar
  13. Hancock, K. and Tsang, V.C.W. 1986. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J. Immunol. Methods 92: 167–176.
    Article CAS Google Scholar
  14. Quakyi, I.A., Carter, R., Rener, J., Kumar, N., Good, M.F. and Miler, L.H. 1987. The 230-kD gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 139: 4213–4217.
    CAS PubMed Google Scholar

Download references